中性粒细胞和淋巴细胞比值与头颈恶性肿瘤放疗过程中口腔黏膜炎的相关性
Correlation between Neutrophil to Lymphocyte Ratio and Oral Mucositis during Radiotherapy for Head and Neck Cancer
摘要: 目的:探讨中性粒细胞与淋巴细胞比值(NLR)对头颈部恶性肿瘤(HNC)放疗患者口腔粘膜炎(OM)的相关性。方法:选取2020年6月至2021年1月在青岛大学附属烟台毓璜顶医院行放射治疗的31例HNC患者为研究对象,依据受试者工作特征曲线(ROC)中NLR最佳截断值分为低NLR组及高NLR组。分别根据WHO标准和OMAS量表对患者OM进行评估,将WHO分级为3级和4级的定义为严重OM。分析放疗前NLR水平与HNC患者放疗过程中OM之间的联系。结果:依据ROC曲线,放疗前NLR的最佳截取值为2.95。根据WHO标准和OMAS标准,高NLR组患者出现严重OM的比例高于低NLR组,且高NLR组的OMAS评分高于低NLR组(均P < 0.05)。在单因素分析中,NLR水平、临床分期、N分期与患者发生严重OM显著相关,logistic多因素回归分析表明影响患者发生严重OM的独立危险因素为NLR水平、N分期;NLR对HNC放疗患者严重OM的发生具有一定的诊断价值(均P < 0.05)。结论:NLR与HNC患者放疗过程中OM严重程度相关,且对严重OM的发生具有一定的预测价值。
Abstract: Objective: To investigate the correlation between neutrophil to lymphocyte ratio (NLR) and oral mucositis (OM) in patients receiving radiotherapy for head and neck cancer (HNC). Methods: A total of 31 HNC patients undergoing radiotherapy in Yantai Yuhuangding Hospital Affiliated to Qingdao University from June 2020 to January 2021 were enrolled. According to the optimal cut-off value of NLR in receiver operating characteristic curve (ROC), they were divided into low NLR group and high NLR group. Patients were evaluated for OM according to WHO criteria and OMAS scale, respec-tively, and those with WHO grading of grade 3 and 4 were defined as severe OM to analyze the asso-ciation between pre-radiotherapy NLR levels and OM during radiotherapy in HNC patients. Results: The ROC indicated that the optimal intercept value of NLR before radiotherapy was 2.95. According to WHO criteria and OMAS criteria, the proportion of patients with severe OM was higher in the high NLR group than in the low NLR group, and the OMAS score was higher in the high NLR group than in the low NLR group (all P < 0.05). In the univariate analysis, NLR level, clinical stage and N stage were significantly associated with the occurrence of severe OM in patients, and multivariate logistic regression analysis showed that the independent risk factors affecting the occurrence of severe OM in patients were NLR level and N stage; NLR had a diagnostic value for the occurrence of severe OM in HNC radiotherapy patients (all P < 0.05).
文章引用:李涛, 宋轶鹏. 中性粒细胞和淋巴细胞比值与头颈恶性肿瘤放疗过程中口腔黏膜炎的相关性[J]. 临床医学进展, 2023, 13(2): 1899-1905. https://doi.org/10.12677/ACM.2023.132263

参考文献

[1] Fitzmaurice, C., Allen, C., Barber, R.M., Barregard, L., Bhutta, Z.A., Brenner, H., et al. (2017) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 3, 524-548. [Google Scholar] [CrossRef] [PubMed]
[2] Huang, T.-L., Chien, C.-Y., Tsai, W.-L., Liao, K.-C., Chou, S.-Y., Lin, H.-C., et al. (2016) Long-Term Late Toxicities and Quality of Life for Survivors of Naso-pharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy versus Non-Intensity-Modulated Radiotherapy. Head & Neck, 38, E1026-E1032. [Google Scholar] [CrossRef] [PubMed]
[3] Song, T., Fang, M., Zhang, X.-B., Zhang, P., Xie, R.-F. and Wu, S.-X. (2015) Sustained Improvement of Quality Of life for Nasopharyngeal Carcinoma Treated by Intensity Modulated Radiation Therapy in Long-Term Survivors. International Journal of Clinical and Experimental Medicine, 8, 5658-5666.
[4] Peng, G., Wang, T., Yang, K.-Y., Zhang, S., Zhang, T., Li, Q., et al. (2012) A Prospective, Randomized Study Comparing Outcomes and Toxicities of Intensity-Modulated Radiotherapy vs. Conventional Two-Dimensional Radiotherapy for the Treatment of Nasopharyngeal Carcinoma. Radiotherapy & Oncology, 104, 286-293. [Google Scholar] [CrossRef] [PubMed]
[5] Trotti, A., Bellm, L.A., Epstein, J.B., Frame, D., Fuchs, H.J., Gwede, C.K., et al. (2003) Mucositis Incidence, Severity and Associated Outcomes in Patients with Head and Neck Cancer Receiving Radiotherapy with or without Chemotherapy: A Systematic Literature Review. Radiotherapy & On-cology, 66, 253-262. [Google Scholar] [CrossRef
[6] 原浩, 韦燕, 梁国栋. 鼻咽癌患者发生重度放射性口腔黏膜炎的危险因素分析[J]. 中国现代医药杂志, 2022, 24(7): 35-38.
[7] 刘建辉, 罗妍, 陈晓, 徐向升, 周平. 放疗前中性粒细胞/淋巴细胞血小板/淋巴细胞预后营养指数及CA19-9与胰腺腺癌放疗后预后关系的分析[J]. 中国肿瘤临床, 2017, 44(6): 289-293.
[8] 汪庚明, 周燕, 孙谦, 丁建明, 周士祥, 陈蔓, 等. 局部晚期下咽癌患者放疗前NLR与PLR对预后的意义[J]. 中华全科医学, 2021, 19(5): 763-766.
[9] 陈阳, 陈方, 施朕善, 王磊. 淋巴细胞与中性粒细胞比值对食管鳞癌患者同步放化疗疗效及预后判断的临床意义[J]. 分子诊断与治疗杂志, 2022, 14(7): 1121-1124.
[10] 颜玲玲, 吴坚芬, 顾彬彬, 叶丽萍. 血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值对早期胃癌诊断的预测价值[J]. 中华消化杂志, 2022, 42(3): 163-170.
[11] 健康时报网. 首部CSCO头颈部肿瘤诊疗指南发布[J]. 中国肿瘤临床与康复, 2019, 26(5): 628.
[12] Peterson, D.E., Boers-Doets, C.B., Bensadoun, R.J. and Herrstedt, J. (2015) Management of Oral and Gastrointestinal Mucosal Injury: ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up. Annals of Oncology, 26, V139-V151. [Google Scholar] [CrossRef] [PubMed]
[13] Sonis, S.T., Eilers, J.P., Epstein, J.B., LeVeque, F.G., Liggett Jr., W.H., Mulagha, M.T., et al. (1999) Validation of a New Scoring System for the Assessment of Clinical Trial Research of Oral Mucositis Induced by Radiation or Chemotherapy. Cancer, 85, 2103-2113. [Google Scholar] [CrossRef
[14] Sonis, S.T. (2009) Mucositis: The Impact, Biology and Therapeutic Opportunities of Oral Mucositis. Oral Oncology, 45, 1015-1020. [Google Scholar] [CrossRef] [PubMed]
[15] Eilers, J. and Million, R. (2007) Prevention and Manage-ment of Oral Mucositis in Patients with Cancer. Seminars in Oncology Nursing, 23, 201-212. [Google Scholar] [CrossRef] [PubMed]
[16] Zenda, S., Matsuura, K., Tachibana, H., Homma, A., Kirita, T., Monden, N., et al. (2011) Multicenter Phase II Study of an Opioid-Based Pain Control Program for Head and Neck Cancer Patients Receiving Chemoradiotherapy. Radiotherapy & Oncology, 101, 410-414. [Google Scholar] [CrossRef] [PubMed]
[17] Lee, Y.H., Choi, H.-S., Jeong, H., Kang, K.M., Song, J.H., Lee, W.S., et al. (2018) Neutrophil-Lymphocyte Ratio and a Dosimetric Factor for Predicting Symptomatic Radiation Pneu-monitis in Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy. The Clinical Respiratory Journal, 12, 1264-1273. [Google Scholar] [CrossRef] [PubMed]
[18] Sonis, S.T. (2013) Oral Mucositis in Head and Neck Cancer: Risk, Biology, and Management. American Society of Clinical Oncology Educational Book, 33, e236-e240. [Google Scholar] [CrossRef
[19] Kang, M., Jeong, C.W., Kwak, C., Kim, H.H. and Ku, J.H. (2016) The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. Annals of Surgical Oncology, 23, 335-342. [Google Scholar] [CrossRef] [PubMed]
[20] Han, S., Liu, Y., Li, Q., Li, Z., Hou, H. and Wu, A. (2015) Pre-Treatment Neutrophil-to-Lymphocyte Ratio Is Associated with Neutrophil and T-Cell Infiltration and Predicts Clini-cal Outcome in Patients with Glioblastoma. BMC Cancer, 15, Article No. 617. [Google Scholar] [CrossRef] [PubMed]
[21] Tham, T., Bardash, Y., Herman, S.W. and Costantino, P.D. (2018) Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Head and Neck Cancer: A Systematic Review and Me-ta-Analysis. Head & Neck, 40, 2546-2557. [Google Scholar] [CrossRef] [PubMed]
[22] Motomura, T., Shirabe, K., Mano, Y., Muto, J., Toshima, T., Umemoto, Y., et al. (2013) Neutrophil-Lymphocyte Ratio Reflects Hepatocellular Carcinoma Recurrence after Liver Transplantation via Inflammatory Microenvironment. Journal of Hepatology, 58, 58-64. [Google Scholar] [CrossRef] [PubMed]
[23] Kantola, T., Klintrup, K., Väyrynen, J.P., Vornanen, J., Bloigu, R., Karhu, T., et al. (2012) Stage-Dependent Alterations of the Serum Cytokine Pattern in Colorectal Carcinoma. British Journal of Cancer, 107, 1729-1736. [Google Scholar] [CrossRef] [PubMed]